These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

701 related items for PubMed ID: 28491862

  • 1. Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease.
    Kittanakom S, Shajib MS, Garvie K, Turner J, Brooks D, Odeh S, Issenman R, Chetty VT, Macri J, Khan WI.
    Can J Gastroenterol Hepatol; 2017; 2017():1450970. PubMed ID: 28491862
    [Abstract] [Full Text] [Related]

  • 2. Comparison of two immunoassays for measurement of faecal calprotectin in detection of inflammatory bowel disease: (pre)-analytical and diagnostic performance characteristics.
    Oyaert M, Trouvé C, Baert F, De Smet D, Langlois M, Vanpoucke H.
    Clin Chem Lab Med; 2014 Mar; 52(3):391-7. PubMed ID: 24114912
    [Abstract] [Full Text] [Related]

  • 3. Analytical Performance and Clinicopathologic Correlation of Four Fecal Calprotectin Methods.
    Pelkmans LPJ, de Groot MJM, Curvers J.
    Am J Clin Pathol; 2019 Aug 01; 152(3):392-398. PubMed ID: 31152542
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Calprotectin levels in patients with idiopathic inflammatory bowel disease comparison of two commercial tests].
    Malícková K, Janatková I, Bortlík M, Komárek V, Lukás M.
    Epidemiol Mikrobiol Imunol; 2008 Nov 01; 57(4):147-53. PubMed ID: 19069028
    [Abstract] [Full Text] [Related]

  • 6. A comparison of diagnostic performance between two quantitative rapid fecal calprotectin assays in detecting active inflammatory bowel disease.
    Lee JM, Jang JH, Ryu JH, Yoo J, Lee BI, Kim SJ, Oh EJ.
    PLoS One; 2021 Nov 01; 16(8):e0255974. PubMed ID: 34383847
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Analytical evaluation of a fully automated immunoassay for faecal calprotectin in a paediatric setting.
    Noebauer B, Ramic L, Konstantin A, Zachbauer C, Einwallner E.
    Biochem Med (Zagreb); 2017 Oct 15; 27(3):030710. PubMed ID: 29180918
    [Abstract] [Full Text] [Related]

  • 12. Agreement Between Home-Based Measurement of Stool Calprotectin and ELISA Results for Monitoring Inflammatory Bowel Disease Activity.
    Heida A, Knol M, Kobold AM, Bootsman J, Dijkstra G, van Rheenen PF.
    Clin Gastroenterol Hepatol; 2017 Nov 15; 15(11):1742-1749.e2. PubMed ID: 28606846
    [Abstract] [Full Text] [Related]

  • 13. Validation of rapid fecal calprotectin assay using particle enhanced turbidimetric immunoassay for inflammatory bowel disease.
    Oka A, Kawashima K, Kishimoto K, Kotani S, Fukunaga M, Fukuba N, Mishima Y, Oshima N, Ishimura N, Awoniyi M, Ishihara S.
    Sci Rep; 2024 Jan 18; 14(1):1653. PubMed ID: 38238442
    [Abstract] [Full Text] [Related]

  • 14. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children.
    Sidler MA, Leach ST, Day AS.
    Inflamm Bowel Dis; 2008 Mar 18; 14(3):359-66. PubMed ID: 18050298
    [Abstract] [Full Text] [Related]

  • 15. A novel turbidimetric immunoassay for fecal calprotectin optimized for routine chemistry analyzers.
    Nilsen T, Sunde K, Hansson LO, Havelka AM, Larsson A.
    J Clin Lab Anal; 2017 Jul 18; 31(4):. PubMed ID: 27629827
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome.
    Otten CM, Kok L, Witteman BJ, Baumgarten R, Kampman E, Moons KG, de Wit NJ.
    Clin Chem Lab Med; 2008 Jul 18; 46(9):1275-80. PubMed ID: 18597588
    [Abstract] [Full Text] [Related]

  • 17. Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome.
    Sydora MJ, Sydora BC, Fedorak RN.
    J Crohns Colitis; 2012 Mar 18; 6(2):207-14. PubMed ID: 22325175
    [Abstract] [Full Text] [Related]

  • 18. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease.
    Konikoff MR, Denson LA.
    Inflamm Bowel Dis; 2006 Jun 18; 12(6):524-34. PubMed ID: 16775498
    [Abstract] [Full Text] [Related]

  • 19. Faecal calprotectin: comparative study of the Quantum Blue rapid test and an established ELISA method.
    Coorevits L, Baert FJ, Vanpoucke HJ.
    Clin Chem Lab Med; 2013 Apr 18; 51(4):825-31. PubMed ID: 23001318
    [Abstract] [Full Text] [Related]

  • 20. Reference Intervals for Fecal Calprotectin in Adults Using Two Different Extraction Methods in the Uppsala-SCAPIS Cohort.
    Fall T, Mandic-Havelka A, Helmersson-Karlqvist J, Sundstrom J, Larsson A.
    Clin Lab; 2017 Sep 01; 63(9):1493-1496. PubMed ID: 28879709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.